We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $3.01B
1-Year Est. Return 119.46%
This Fund
S&P 500
This Quarter Est. Return
-0.9%
1 Year Est. Return
+119.46%
3 Year Est. Return
+340.9%
5 Year Est. Return
+347.01%
10 Year Est. Return
+3,143.27%
AUM
$2.72B
AUM Growth
-$309M
Cap. Flow
+$81.1M
Cap. Flow %
2.98%
Top 10 Hldgs %
40.44%
Holding
175
New
22
Increased
46
Reduced
28
Closed
23

Top Buys

Rank Stock Value
1
PTON icon
Peloton Interactive
PTON
+$29.6M
2
MLYS icon
Mineralys Therapeutics
MLYS
+$22.9M
3
CWH icon
Camping World
CWH
+$22.7M
4
VSTM icon
Verastem
VSTM
+$19.3M
5
TBBK icon
The Bancorp
TBBK
+$18.5M

Top Sells

Rank Stock Value
1
TNGX icon
Tango Therapeutics
TNGX
+$32.3M
2
EB
Eventbrite
EB
+$30.5M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$30.2M
4
RAPT
RAPT Therapeutics
RAPT
+$25.5M
5
GMED icon
Globus Medical
GMED
+$19.6M

Sector Composition

Rank Sector Weight
1 Miscellaneous 41.58%
2 Healthcare 36%
3 Consumer Discretionary 9.68%
4 Financials 3.92%
5 Communication Services 2.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IWM icon
1
PUT
iShares Russell 2000 ETF
IWM
$80.8B
$508M 18.72%
2,050,000
-650,000
-24% -$168M
HLF icon
2
CALL
Herbalife
HLF
$1.3B
$82.4M 3.03%
5,600,000
-2,200,000
-28% -$35.9M
PTON icon
3
CALL
Peloton Interactive
PTON
$2.39B
$77M 2.83%
17,938,900
+11,438,900
+176% +$55.8M
TBBK icon
4
The Bancorp
TBBK
$2.68B
$74.2M 2.73%
1,380,456
+308,771
+29% +$18.5M
VTRS icon
5
CALL
Viatris
VTRS
$18.8B
$67.5M 2.49%
5,000,000
– –
EW icon
6
PUT
Edwards Lifesciences
EW
$52B
$64.1M 2.36%
800,000
-1,000,000
-56% -$82.4M
HGV icon
7
Hilton Grand Vacations
HGV
$3.41B
$59.2M 2.18%
1,513,656
-47,966
-3% -$2.15M
SLNO
8
DELISTED
Soleno Therapeutics
SLNO
$58.4M 2.15%
1,744,124
+430,122
+33% +$16.9M
BVS icon
9
Bioventus
BVS
$945M
$55.9M 2.06%
6,122,403
+75,000
+1% +$629K
PTON icon
10
Peloton Interactive
PTON
$2.39B
$51.5M 1.9%
12,000,000
+6,067,324
+102% +$29.6M
ESTA icon
11
Establishment Labs
ESTA
$2.11B
$47.3M 1.74%
832,956
-154,733
-16% -$10.6M
TEVA icon
12
CALL
Teva Pharmaceuticals
TEVA
$42.5B
$45.2M 1.66%
1,500,000
-1,000,000
-40% -$32.2M
QURE icon
13
CALL
uniQure
QURE
$3.38B
$42.5M 1.57%
+2,600,000
New +$52.6M
HGV icon
14
CALL
Hilton Grand Vacations
HGV
$3.41B
$42.1M 1.55%
1,075,000
– –
SVRA icon
15
Savara
SVRA
$1.08B
$40.1M 1.48%
7,344,783
– –
XBI icon
16
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.3B
$38.3M 1.41%
300,000
-100,000
-25% -$12.5M
XTNT icon
17
Xtant Medical Holdings
XTNT
$53.9M
$38.2M 1.41%
68,394,000
– –
GOGO icon
18
Gogo Inc
GOGO
$369M
$35.7M 1.31%
8,882,036
+2,089,387
+31% +$9.52M
AMRX icon
19
Amneal Pharmaceuticals
AMRX
$6.11B
$35.4M 1.3%
2,844,108
+396,592
+16% +$5.32M
REGN icon
20
CALL
Regeneron Pharmaceuticals
REGN
$81.8B
$30.9M 1.14%
40,000
– –
AVR
21
Anteris Technologies
AVR
$852M
$30.7M 1.13%
5,530,910
+3,000,000
+119% +$17.2M
ETON icon
22
Eton Pharmaceutcials
ETON
$1.71B
$29M 1.07%
1,175,951
– –
EOLS icon
23
Evolus
EOLS
$587M
$26.2M 0.96%
6,376,857
+556,208
+10% +$2.7M
TNGX icon
24
Tango Therapeutics
TNGX
$3.94B
$26.2M 0.96%
1,250,452
-2,322,181
-65% -$32.3M
LBRX
25
LB Pharmaceuticals
LBRX
$1.54B
$26M 0.96%
1,052,894
+377,894
+56% +$8.72M
1
2 3 4 5

Similar funds

MYLI
Meiji Yasuda Life Insurance Tokyo, Japan $3.01B AUM 7.86% 1-Year Est. Return
SIC
Schwartz Investment Counsel Plymouth, Michigan $3.01B AUM 27.22% 1-Year Est. Return
HFM
Harvest Fund Management Beijing, China $3.02B AUM 91.56% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return
HP
Hosking Partners London, United Kingdom $3.01B AUM 83.99% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return
SI
Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return

Nantahala Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Nantahala Capital Management held 175 positions worth $2.72B, down 10% from $3.02B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Nantahala Capital Management's Q1 2026 filing shows 22 new, 46 increased, 28 reduced and 23 closed positions. Its largest new stake was AgomAb Therapeutics NV: 1,200,000 shares worth $12.9M. The largest sale was Tango Therapeutics, an estimated $32.3M.

By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, down from 46% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Nantahala Capital Management's largest Q1 2026 buy was AgomAb Therapeutics NV: 1,200,000 shares worth $12.9M.
  • Nantahala Capital Management added most to Peloton Interactive in Q1 2026, an estimated $29.6M increase.
  • Nantahala Capital Management's biggest Q1 2026 reduction was Tango Therapeutics, cutting an estimated $32.3M.
  • Nantahala Capital Management fully exited Eventbrite in Q1 2026, selling an estimated $30.5M.
  • Nantahala Capital Management's ten largest holdings make up 40% of its $2.72B portfolio in Q1 2026.
  • Nantahala Capital Management opened 22 new positions and closed 23 in Q1 2026.
  • Nantahala Capital Management's portfolio value fell 10% quarter-over-quarter to $2.72B.

Based on Nantahala Capital Management's 13F filing for Q1 2026, filed 15 May 2026.